Marex Group PLC Fundamental Analysis
Marex Group PLC (MRX) shows moderate financial fundamentals with a PE ratio of 20.04, profit margin of 8.49%, and ROE of 25.95%. The company generates $3.7B in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 62.7/100 based on profitability, valuation, growth, and balance sheet metrics. The C+ grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze MRX's fundamental strength across five key dimensions:
Efficiency Score
WeakMRX struggles to generate sufficient returns from assets.
Valuation Score
ModerateMRX shows balanced valuation metrics.
Growth Score
ModerateMRX shows steady but slowing expansion.
Financial Health Score
ModerateMRX shows balanced financial health with some risks.
Profitability Score
ModerateMRX maintains healthy but balanced margins.
Key Financial Metrics
Is MRX Expensive or Cheap?
P/E Ratio
MRX trades at 20.04 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, MRX's PEG of 5.23 indicates potential overvaluation.
Price to Book
The market values Marex Group PLC at 3.37 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 0.36 times EBITDA. This is generally considered low.
How Well Does MRX Make Money?
Net Profit Margin
For every $100 in sales, Marex Group PLC keeps $8.49 as profit after all expenses.
Operating Margin
Core operations generate 31.98 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $25.95 in profit for every $100 of shareholder equity.
ROA
Marex Group PLC generates $0.89 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Marex Group PLC produces operating cash flow of $672.91M, showing steady but balanced cash generation.
Free Cash Flow
Marex Group PLC generates strong free cash flow of $659.70M, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $9.17 in free cash annually.
FCF Yield
MRX converts 15.44% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
20.04
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
5.23
vs 25 benchmark
P/B Ratio
Price to book value ratio
3.37
vs 25 benchmark
P/S Ratio
Price to sales ratio
1.18
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
8.10
vs 25 benchmark
Current Ratio
Current assets to current liabilities
3.16
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.26
vs 25 benchmark
ROA
Return on assets percentage
0.009
vs 25 benchmark
ROCE
Return on capital employed
0.04
vs 25 benchmark
How MRX Stacks Against Its Sector Peers
| Metric | MRX Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 20.04 | 21.02 | Neutral |
| ROE | 25.95% | 634.00% | Weak |
| Net Margin | 8.49% | -1049.00% (disorted) | Weak |
| Debt/Equity | 8.10 | 1.52 | Weak (High Leverage) |
| Current Ratio | 3.16 | 924.95 | Strong Liquidity |
| ROA | 0.89% | -836.00% (disorted) | Weak |
MRX outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Marex Group PLC's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Value, Dividend, Cyclical
EPS CAGR
N/A
Industry Style: Value, Dividend, Cyclical
FCF CAGR
N/A
Industry Style: Value, Dividend, Cyclical